{Reference Type}: Journal Article
{Title}: Inhibition of somatostatin enhances the long-term metabolic outcomes of sleeve gastrectomy in mice.
{Author}: Kleiman D;Arad Y;Azulai S;Baker A;Bergel M;Elad A;Haran A;Hefetz L;Israeli H;Littor M;Permyakova A;Samuel I;Tam J;Ben-Haroush Schyr R;Ben-Zvi D;
{Journal}: Mol Metab
{Volume}: 86
{Issue}: 0
{Year}: 2024 Aug 28
{Factor}: 8.568
{DOI}: 10.1016/j.molmet.2024.101979
{Abstract}: OBJECTIVE: Bariatric surgery is an effective treatment to obesity, leading to weight loss and improvement in glycemia, that is characterized by hypersecretion of gastrointestinal hormones. However, weight regain and relapse of hyperglycemia are not uncommon. We set to identify mechanisms that can enhance gastrointestinal hormonal secretion following surgery to sustain weight loss.
METHODS: We investigated the effect of somatostatin (Sst) inhibition on the outcomes of bariatric surgery using a mouse model of sleeve gastrectomy (SG).
RESULTS: Sst knockout (sst-ko) mice fed with a calorie-rich diet gained weight normally and had a mild favorable metabolic phenotype compared to heterozygous sibling controls, including elevated plasma levels of GLP-1. Mathematical modeling of the feedback inhibition between Sst and GLP-1 showed that Sst exerts its maximal effect on GLP-1 under conditions of high hormonal stimulation, such as following SG. Obese sst-ko mice that underwent SG had higher levels of GLP-1 compared with heterozygous SG-operated controls. The SG-sst-ko mice regained less weight than controls and maintained lower glycemia months after surgery. Obese wild-type mice that underwent SG and were treated daily with a Sst receptor inhibitor for two months had higher GLP-1 levels, regained less weight, and improved metabolic profile compared to saline-treated SG-operated controls, and compared to inhibitor or saline-treated sham-operated obese mice.
CONCLUSIONS: Our results suggest that inhibition of Sst signaling enhances the long-term favorable metabolic outcomes of bariatric surgery.